Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG – Research Report), Andlauer Healthcare Group (ANDHF – Research Report) and MoonLake Immunotherapeutics (MLTX – Research Report).
Galapagos (GLPG)
In a report issued on November 3, Brian Abrahams from RBC Capital maintained a Hold rating on Galapagos, with a price target of $38.00. The company’s shares closed last Friday at $37.06.
According to TipRanks.com, Abrahams is a 4-star analyst with an average return of
Galapagos has an analyst consensus of Moderate Buy, with a price target consensus of $39.00.
See Insiders’ Hot Stocks on TipRanks >>
Andlauer Healthcare Group (ANDHF)
RBC Capital analyst Walter Spracklin maintained a Hold rating on Andlauer Healthcare Group on November 3 and set a price target of C$41.00. The company’s shares closed last Friday at $37.80.
According to TipRanks.com, Spracklin is a 5-star analyst with an average return of
Andlauer Healthcare Group has an analyst consensus of Moderate Buy, with a price target consensus of $32.34.
MoonLake Immunotherapeutics (MLTX)
In a report released today, Andreas Argyrides from Wedbush reiterated a Buy rating on MoonLake Immunotherapeutics, with a price target of $86.00. The company’s shares closed last Friday at $51.28.
According to TipRanks.com, Argyrides ‘ ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Currently, the analyst consensus on MoonLake Immunotherapeutics is a Strong Buy with an average price target of $71.36, implying a 49.0% upside from current levels. In a report issued on November 1, Stifel Nicolaus also initiated coverage with a Buy rating on the stock with a $74.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GLPG:
